{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:31:49Z","timestamp":1740123109910,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11033-018-4168-x","type":"journal-article","created":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T15:24:04Z","timestamp":1521732244000},"page":"347-351","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Acute myeloid leukemia with translocation (1;21)"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6158-4861","authenticated-orcid":false,"given":"Ameer","family":"Hamza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uqba","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidrah","family":"Khawar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Snower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"issue":"1","key":"4168_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1046\/j.1365-2141.2002.03369.x","volume":"117","author":"DK Webb","year":"2002","unstructured":"Webb DK, Passmore SJ, Hann IM, Harrison G, Wheatley K, Chessells JM (2002) Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99. Br J Haematol 117(1):33\u201339","journal-title":"Br J Haematol"},{"issue":"12","key":"4168_CR2","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1182\/blood.V95.12.4011","volume":"95","author":"R Hromas","year":"2000","unstructured":"Hromas R, Shopnick R, Jumean HG, Bowers C, Varella-Garcia M, Richkind K (2000) A novel syndrome of radiation-associated acute myeloid leukemia involving AML1 gene translocations. Blood 95(12):4011\u20134013","journal-title":"Blood"},{"issue":"8","key":"4168_CR3","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1182\/blood.V92.8.2879","volume":"92","author":"D Roulston","year":"1998","unstructured":"Roulston D, Espinosa R 3rd, Nucifora G, Larson RA, Le Beau MM, Rowley JD (1998) CBFA2(AML1) translocations with novel partner chromosomes in myeloid leukemias: association with prior therapy. Blood 92(8):2879\u20132885","journal-title":"Blood"},{"issue":"6","key":"4168_CR4","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/sj.leu.2404210","volume":"20","author":"MJ Stevens-Kroef","year":"2006","unstructured":"Stevens-Kroef MJ, Schoenmakers EF, van Kraaij M, Huys E, Vermeulen S, van der Reijden B, van Kessel AG (2006) Identification of truncated RUNX1 and RUNX1-PRDM16 fusion transcripts in a case of t(1;21)(p36;q22)-positive therapy-related AML. Leukemia 20(6):1187\u20131189","journal-title":"Leukemia"},{"issue":"3","key":"4168_CR5","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/gcc.20241","volume":"44","author":"I Sakai","year":"2005","unstructured":"Sakai I, Tamura T, Narumi H, Uchida N, Yakushijin Y, Hato T, Fujita S, Yasukawa M (2005) Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22). Genes Chromosom Cancer 44(3):265\u2013270","journal-title":"Genes Chromosom Cancer"},{"issue":"9","key":"4168_CR6","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1182\/blood.V96.9.3209","volume":"96","author":"N Mochizuki","year":"2000","unstructured":"Mochizuki N, Shimizu S, Nagasawa T, Tanaka H, Taniwaki M, Yokota J, Morishita K (2000) A novel gene, MEL1, mapped to 1p36.3 is highly homologous to the MDS1\/EVI1 gene and is transcriptionally activated in t(1;3)(p36;q21)-positive leukemia cells. Blood 96(9):3209\u20133214","journal-title":"Blood"},{"key":"4168_CR7","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2017) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th\u00a0edn. International Agency for Research on Cancer, Lyon","edition":"4th"},{"issue":"2","key":"4168_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1309\/8VJ4V9PG3TRJTLVH","volume":"125","author":"L Huang","year":"2006","unstructured":"Huang L, Abruzzo LV, Valbuena JR, Medeiros LJ, Lin P (2006) Acute myeloid leukemia associated with variant t(8;21) detected by conventional cytogenetic and molecular studies: a report of four cases and review of the literature. Am J Clin Pathol 125(2):267\u2013272","journal-title":"Am J Clin Pathol"},{"issue":"19","key":"4168_CR9","doi-asserted-by":"publisher","first-page":"5057","DOI":"10.1182\/blood-2010-08-300145","volume":"117","author":"F Aguilo","year":"2011","unstructured":"Aguilo F, Avagyan S, Labar A et al (2011) Prdm16 is a physiologic regulator of hematopoietic stem cells. Blood 117(19):5057\u20135066. https:\/\/doi.org\/10.1182\/blood-2010-08-300145","journal-title":"Blood"},{"issue":"7","key":"4168_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/gcc.22064","volume":"52","author":"N Shiba","year":"2013","unstructured":"Shiba N, Ichikawa H, Taki T, Park MJ, Jo A, Mitani S, Kobayashi T, Shimada A, Sotomatsu M, Arakawa H, Adachi S, Tawa A, Horibe K, Tsuchida M, Hanada R, Tsukimoto I, Hayashi Y (2013) NUP98-NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia. Genes Chromosom Cancer 52(7):683\u2013693. https:\/\/doi.org\/10.1002\/gcc.22064","journal-title":"Genes Chromosom Cancer"},{"issue":"12","key":"4168_CR11","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.1038\/leu.2013.87","volume":"27","author":"JD Rooij de","year":"2013","unstructured":"de Rooij JD, Hollink IH, Arentsen-Peters ST, van Galen JF, Berna Beverloo H, Baruchel A, Trka J, Reinhardt D, Sonneveld E, Zimmermann M, Alonzo TA, Pieters R, Meshinchi S, van den Heuvel-Eibrink MM, Zwaan CM (2013) NUP98\/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression pattern. Leukemia 27(12):2280\u20132288. https:\/\/doi.org\/10.1038\/leu.2013.87","journal-title":"Leukemia"},{"issue":"11","key":"4168_CR12","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/gcc.22483","volume":"56","author":"G Yamato","year":"2017","unstructured":"Yamato G, Yamaguchi H, Handa H, Shiba N, Kawamura M, Wakita S, Inokuchi K, Hara Y, Ohki K, Okubo J, Park MJ, Sotomatsu M, Arakawa H, Hayashi Y (2017) Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemia. Genes Chromosom Cancer 56(11):800\u2013809. https:\/\/doi.org\/10.1002\/gcc.22483","journal-title":"Genes Chromosom Cancer"},{"issue":"5","key":"4168_CR13","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/leu.2015.5","volume":"29","author":"A Jo","year":"2015","unstructured":"Jo A, Mitani S, Shiba N, Hayashi Y, Hara Y, Takahashi H, Tsukimoto I, Tawa A, Horibe K, Tomizawa D, Taga T, Adachi S, Yoshida T, Ichikawa H (2015) High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. Leukemia 29(5):1076\u20131083. https:\/\/doi.org\/10.1038\/leu.2015.5","journal-title":"Leukemia"},{"issue":"4","key":"4168_CR14","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/bjh.13869","volume":"172","author":"N Shiba","year":"2016","unstructured":"Shiba N, Ohki K, Kobayashi T, Hara Y, Yamato G, Tanoshima R, Ichikawa H, Tomizawa D, Park MJ, Shimada A, Sotomatsu M, Arakawa H, Horibe K, Adachi S, Taga T, Tawa A, Hayashi Y (2016) High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia\/Lymphoma Study Group AML-05 trial. Br J Haematol 172(4):581\u2013591. https:\/\/doi.org\/10.1111\/bjh.13869","journal-title":"Br J Haematol"},{"issue":"6","key":"4168_CR15","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/ijlh.12101","volume":"35","author":"E Bae","year":"2013","unstructured":"Bae E, Park CJ, Cho YU, Seo EJ, Chi HS, Jang S, Lee KH, Lee JH, Lee JH, Suh JJ, Im HJ (2013) Differential diagnosis of myelofibrosis based on WHO 2008 criteria: acute panmyelosis with myelofibrosis, acute megakaryoblastic leukemia with myelofibrosis, primary myelofibrosis and myelodysplastic syndrome with myelofibrosis. Int J Lab Hematol 35(6):629\u2013636. https:\/\/doi.org\/10.1111\/ijlh.12101","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"4168_CR16","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/blood-2006-12-062125","volume":"110","author":"A Theocharides","year":"2007","unstructured":"Theocharides A, Boissinot M, Girodon F, Garand R, Teo SS, Lippert E, Talmant P, Tichelli A, Hermouet S, Skoda RC (2007) Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation. Blood 110(1):375\u2013379","journal-title":"Blood"},{"key":"4168_CR17","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/gcc.10042","volume":"33","author":"ML Slovak","year":"2002","unstructured":"Slovak ML, Bedell V, Popplewell L, Arber DA, Schoch C, Slater R (2002) 21q22 balanced chromosome aberrations in therapy-related hematopoietic disorders: report from an international workshop. Genes Chromosom Cancer 33:379\u2013394","journal-title":"Genes Chromosom Cancer"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11033-018-4168-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-018-4168-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T23:53:47Z","timestamp":1604015627000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11033-018-4168-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["4168"],"URL":"https:\/\/doi.org\/10.1007\/s11033-018-4168-x","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"5 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Formal consent was obtained from the Hospital ethical committee and the manuscript is in accordance with the recommendations of Institutional Review Board of St. John, Hospital and Medical Center, Detroit, MI, USA. The manuscript complies with institutional, national, and international guidelines for using human subject\/tissue.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}